Kenneth W. O'Keefe
Director, Jazz Pharmaceuticals.
Companies
- Jazz PharmaceuticalsBoard member May 31, 2007 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jazz Pharmaceuticals JAZZ30,256 shares2$6.3M at $207.05Dec 4, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 2, 2025Shares withheld for tax 603 shares at $173.07 of Jazz Pharmaceuticals2
- Aug 8, 2025Shares withheld for tax 1,805 shares at $111.25 of Jazz Pharmaceuticals3
- Aug 7, 2025Granted 3,507 shares of Jazz Pharmaceuticals3
- Aug 6, 2024Shares withheld for tax 1,484 shares at $111.35 of Jazz Pharmaceuticals4
- Aug 2, 2024Granted 3,731 shares of Jazz Pharmaceuticals4
- Aug 14, 2023Sold 1,241 shares at $138.16 of Jazz Pharmaceuticals5
- Aug 11, 2023Granted 3,075 shares of Jazz Pharmaceuticals5
- Mar 7, 2023Sold 2,690 shares at $138.39 of Jazz Pharmaceuticals6
- Mar 7, 2023Exercised options 4,500 shares at $81.76 of Jazz Pharmaceuticals6
- Aug 8, 2022Sold 1,089 shares at $152.33 of Jazz Pharmaceuticals7
- Aug 5, 2022Granted 2,561 shares of Jazz Pharmaceuticals7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARJazz Pharmaceuticals, Board member
- 2
- 3SEC EDGARForm 4 filed Aug 11, 2025
- 4SEC EDGARForm 4 filed Aug 6, 2024
- 5SEC EDGARForm 4 filed Aug 15, 2023
- 6SEC EDGARForm 4 filed Mar 9, 2023
- 7SEC EDGARForm 4 filed Aug 9, 2022